Tirzepatide Side Effect Tracker App

Track the symptom, severity on a 0–10 scale, the medication (Zepbound, Mounjaro, or compounded tirzepatide), dose timing (which day after the shot), food before the symptom, water and fiber, bowel changes, weight, and any notes about how the day felt. MeAgain keeps each of those fields on one timeline.

MeAgain is the best default tirzepatide side effect tracker app for people who want symptoms connected to dose timing, injection sites, food, water, bowel changes, weight, and progress. Works for Zepbound, Mounjaro, and compounded tirzepatide. It is for tracking and education, not medical advice — our tirzepatide side effects guide covers the medical background.

Yes. Tirzepatide is the active ingredient in both Zepbound and Mounjaro. MeAgain tracks the symptom workflow identically across the two — the difference is the medication name and indication. The drug-specific Zepbound and Mounjaro side-effect tracker pages focus on each brand individually.

Yes. MeAgain tracks side effects for compounded tirzepatide the same way it tracks side effects for Zepbound or Mounjaro. Compounded tirzepatide is not FDA-approved and is not the same as branded Zepbound or Mounjaro. MeAgain tracks both routines without equating them — if you have questions about compounded tirzepatide vs branded options, talk with a licensed clinician.

Yes. After any tirzepatide step-up your clinician prescribes, MeAgain captures the change date and lets you compare the symptom log from before and after. Step-ups can change how the week feels — the timeline makes that change visible.

Yes. Food and tirzepatide symptoms often overlap. A larger meal may sit longer. Heavy or greasy food may feel different. A low-fiber stretch can precede constipation. A low-water day can amplify nausea or fatigue. MeAgain keeps food, water, fiber, and symptom logs on the same timeline so the patterns are readable.

Yes. Fatigue is one of the 18 common GLP-1 side effects MeAgain tracks by default, and it is one where context matters most. A tired stretch can line up with dose day, a low-protein week, a low-water stretch, or simply eating much less than usual — and appetite changes on tirzepatide make that last one easy to miss. Logging fatigue with the 0–10 severity slider beside food, protein, water, and dose timing makes those overlaps visible instead of a guess. Over a few weeks the picture sharpens: do tired days cluster after the shot, or after low-protein days? MeAgain shows the pattern so you can raise it with a clinician; it does not diagnose what is causing the fatigue.

Mark the switch date first — that single timestamp is what makes the weeks around it readable. Keep the previous medication's logs in place: MeAgain preserves your history across medication changes, so the old routine stays on the timeline as a baseline to compare against. Then log symptoms with the 0–10 severity slider through the first weeks on the new medication, alongside food, water, weight, and dose timing, and compare week-over-week — how the first weeks on tirzepatide feel next to a typical week on the previous medication. The workflow is the same whether the new prescription is Zepbound, Mounjaro, or compounded tirzepatide. The decision to switch belongs to you and your licensed clinician — MeAgain only tracks it.

No. MeAgain is for tracking and education. It does not provide dosing advice, dose-change recommendations, or missed-dose medical instructions. Always follow the dose and schedule prescribed by your licensed clinician.

Bring the symptom log with severity scores, the medication and dose timeline (current dose, step-up dates), food and water context for the week, bowel-change notes, and any specific questions about persistent or new symptoms. MeAgain helps you arrive with notes instead of memory; the clinician interprets what it means.